| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vertebroplasty | 39 | 2024 | 78 | 14.070 |
Why?
|
| Low Back Pain | 54 | 2024 | 984 | 12.490 |
Why?
|
| Fractures, Compression | 38 | 2024 | 131 | 11.770 |
Why?
|
| Injections, Epidural | 42 | 2023 | 201 | 11.210 |
Why?
|
| Spinal Fractures | 49 | 2024 | 705 | 10.350 |
Why?
|
| Zygapophyseal Joint | 23 | 2024 | 128 | 9.980 |
Why?
|
| Medicare | 86 | 2024 | 6770 | 7.640 |
Why?
|
| Spinal Stenosis | 20 | 2024 | 261 | 7.180 |
Why?
|
| Patient Protection and Affordable Care Act | 37 | 2024 | 1188 | 7.050 |
Why?
|
| Kyphoplasty | 18 | 2024 | 44 | 6.940 |
Why?
|
| Back Pain | 23 | 2024 | 545 | 6.230 |
Why?
|
| Thrombectomy | 48 | 2023 | 705 | 5.570 |
Why?
|
| Radiculopathy | 13 | 2023 | 202 | 4.990 |
Why?
|
| Stroke | 109 | 2023 | 9758 | 4.770 |
Why?
|
| Nerve Block | 17 | 2024 | 706 | 4.740 |
Why?
|
| Radiology | 31 | 2024 | 2113 | 4.550 |
Why?
|
| Lumbar Vertebrae | 35 | 2024 | 1879 | 4.410 |
Why?
|
| Osteoporotic Fractures | 19 | 2024 | 411 | 4.270 |
Why?
|
| Neurosurgery | 21 | 2024 | 679 | 4.240 |
Why?
|
| Brain Ischemia | 52 | 2023 | 3049 | 4.140 |
Why?
|
| Steroids | 13 | 2022 | 929 | 3.990 |
Why?
|
| Endovascular Procedures | 59 | 2024 | 2183 | 3.910 |
Why?
|
| Anesthetics, Local | 21 | 2023 | 997 | 3.890 |
Why?
|
| Neck Pain | 10 | 2022 | 190 | 3.780 |
Why?
|
| Evidence-Based Medicine | 43 | 2024 | 3688 | 3.750 |
Why?
|
| Bone Cements | 21 | 2023 | 325 | 3.580 |
Why?
|
| Physicians | 31 | 2023 | 4591 | 3.480 |
Why?
|
| International Classification of Diseases | 10 | 2016 | 909 | 3.010 |
Why?
|
| Health Expenditures | 24 | 2021 | 2366 | 2.950 |
Why?
|
| Neuroradiography | 9 | 2015 | 71 | 2.780 |
Why?
|
| United States | 174 | 2024 | 72335 | 2.770 |
Why?
|
| Neurosurgical Procedures | 22 | 2024 | 2072 | 2.770 |
Why?
|
| Sciatica | 4 | 2022 | 97 | 2.740 |
Why?
|
| Reimbursement Mechanisms | 15 | 2019 | 667 | 2.680 |
Why?
|
| Pain | 31 | 2023 | 5073 | 2.630 |
Why?
|
| Failed Back Surgery Syndrome | 4 | 2023 | 20 | 2.550 |
Why?
|
| Humans | 669 | 2024 | 761572 | 2.490 |
Why?
|
| Health Care Reform | 14 | 2017 | 1247 | 2.480 |
Why?
|
| Polymethyl Methacrylate | 8 | 2020 | 131 | 2.420 |
Why?
|
| Cerebral Angiography | 32 | 2023 | 1281 | 2.370 |
Why?
|
| Embolization, Therapeutic | 25 | 2024 | 1418 | 2.280 |
Why?
|
| Neurology | 11 | 2020 | 780 | 2.160 |
Why?
|
| Radiology, Interventional | 13 | 2024 | 476 | 2.050 |
Why?
|
| Radiography, Interventional | 17 | 2021 | 1121 | 1.980 |
Why?
|
| Diskectomy, Percutaneous | 7 | 2013 | 14 | 1.930 |
Why?
|
| Prospective Payment System | 8 | 2018 | 136 | 1.930 |
Why?
|
| Adrenal Cortex Hormones | 9 | 2021 | 1881 | 1.900 |
Why?
|
| Intracranial Aneurysm | 20 | 2021 | 1285 | 1.880 |
Why?
|
| Sacroiliac Joint | 9 | 2023 | 57 | 1.870 |
Why?
|
| Thrombolytic Therapy | 32 | 2023 | 2064 | 1.860 |
Why?
|
| Lidocaine | 7 | 2023 | 538 | 1.810 |
Why?
|
| Analgesics, Opioid | 18 | 2023 | 3808 | 1.800 |
Why?
|
| Periodicals as Topic | 13 | 2020 | 1463 | 1.770 |
Why?
|
| Insurance, Health, Reimbursement | 8 | 2020 | 385 | 1.740 |
Why?
|
| Randomized Controlled Trials as Topic | 40 | 2024 | 10212 | 1.730 |
Why?
|
| Anesthesia, Epidural | 4 | 2021 | 233 | 1.730 |
Why?
|
| Cerebral Revascularization | 12 | 2018 | 259 | 1.720 |
Why?
|
| Spinal Cord | 8 | 2023 | 1819 | 1.700 |
Why?
|
| Fee Schedules | 8 | 2023 | 87 | 1.680 |
Why?
|
| Perioperative Care | 4 | 2024 | 1036 | 1.670 |
Why?
|
| Analgesics | 7 | 2019 | 1070 | 1.630 |
Why?
|
| Injections, Intra-Articular | 10 | 2022 | 280 | 1.590 |
Why?
|
| Treatment Outcome | 138 | 2024 | 64684 | 1.580 |
Why?
|
| Practice Guidelines as Topic | 28 | 2024 | 7391 | 1.560 |
Why?
|
| National Health Insurance, United States | 5 | 2013 | 100 | 1.540 |
Why?
|
| Sacrum | 5 | 2018 | 276 | 1.530 |
Why?
|
| Coronavirus Infections | 12 | 2020 | 3086 | 1.530 |
Why?
|
| Medicare Payment Advisory Commission | 7 | 2018 | 14 | 1.530 |
Why?
|
| Health Policy | 11 | 2018 | 2684 | 1.520 |
Why?
|
| Medicaid | 13 | 2017 | 2818 | 1.520 |
Why?
|
| Pneumonia, Viral | 12 | 2020 | 3206 | 1.510 |
Why?
|
| Health Care Costs | 19 | 2018 | 3242 | 1.500 |
Why?
|
| Pandemics | 22 | 2023 | 8656 | 1.480 |
Why?
|
| Electric Stimulation Therapy | 4 | 2024 | 628 | 1.450 |
Why?
|
| Physician Incentive Plans | 5 | 2017 | 164 | 1.380 |
Why?
|
| Spinal Diseases | 6 | 2020 | 564 | 1.370 |
Why?
|
| Comparative Effectiveness Research | 5 | 2014 | 709 | 1.360 |
Why?
|
| Denervation | 5 | 2023 | 265 | 1.330 |
Why?
|
| United States Dept. of Health and Human Services | 6 | 2017 | 88 | 1.330 |
Why?
|
| Arterial Occlusive Diseases | 12 | 2024 | 748 | 1.320 |
Why?
|
| Fee-for-Service Plans | 10 | 2023 | 700 | 1.310 |
Why?
|
| Arthralgia | 5 | 2022 | 461 | 1.310 |
Why?
|
| Tissue Plasminogen Activator | 17 | 2019 | 1164 | 1.290 |
Why?
|
| Fibrinolytic Agents | 19 | 2023 | 2084 | 1.280 |
Why?
|
| Epidural Space | 4 | 2021 | 122 | 1.280 |
Why?
|
| Anticoagulants | 8 | 2024 | 4812 | 1.270 |
Why?
|
| Fractures, Spontaneous | 4 | 2022 | 231 | 1.260 |
Why?
|
| Opioid-Related Disorders | 9 | 2022 | 2164 | 1.260 |
Why?
|
| Guidelines as Topic | 6 | 2013 | 1386 | 1.250 |
Why?
|
| Medicare Part B | 2 | 2023 | 117 | 1.220 |
Why?
|
| Lumbosacral Region | 9 | 2022 | 293 | 1.210 |
Why?
|
| Reimbursement, Incentive | 5 | 2017 | 543 | 1.210 |
Why?
|
| Bibliometrics | 6 | 2022 | 352 | 1.190 |
Why?
|
| Platelet-Rich Plasma | 2 | 2022 | 178 | 1.190 |
Why?
|
| Intracranial Arteriovenous Malformations | 8 | 2015 | 366 | 1.170 |
Why?
|
| Platelet Aggregation Inhibitors | 6 | 2024 | 2751 | 1.130 |
Why?
|
| Radiology Information Systems | 2 | 2022 | 529 | 1.100 |
Why?
|
| Societies, Medical | 18 | 2024 | 3905 | 1.100 |
Why?
|
| Advisory Committees | 5 | 2017 | 787 | 1.100 |
Why?
|
| Tissue Adhesions | 2 | 2019 | 218 | 1.090 |
Why?
|
| Clinical Coding | 3 | 2020 | 181 | 1.080 |
Why?
|
| Decompression, Surgical | 6 | 2024 | 607 | 1.050 |
Why?
|
| Job Satisfaction | 3 | 2020 | 544 | 1.030 |
Why?
|
| Injections, Spinal | 3 | 2017 | 318 | 1.030 |
Why?
|
| Quality of Health Care | 8 | 2017 | 4330 | 1.010 |
Why?
|
| Aged | 159 | 2024 | 169310 | 1.010 |
Why?
|
| Pain Measurement | 20 | 2023 | 3551 | 1.010 |
Why?
|
| Spine | 5 | 2022 | 1118 | 1.000 |
Why?
|
| Retrospective Studies | 102 | 2024 | 80646 | 0.990 |
Why?
|
| Current Procedural Terminology | 3 | 2019 | 89 | 0.970 |
Why?
|
| Cerebrovascular Disorders | 12 | 2017 | 1474 | 0.960 |
Why?
|
| Peer Review | 3 | 2016 | 217 | 0.940 |
Why?
|
| Polyvinyls | 7 | 2016 | 154 | 0.940 |
Why?
|
| Analgesia, Epidural | 3 | 2017 | 332 | 0.930 |
Why?
|
| Fluoroscopy | 11 | 2023 | 947 | 0.930 |
Why?
|
| Journal Impact Factor | 5 | 2019 | 153 | 0.920 |
Why?
|
| Clinical Trials as Topic | 18 | 2019 | 8002 | 0.920 |
Why?
|
| Certification | 5 | 2019 | 418 | 0.910 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2020 | 499 | 0.910 |
Why?
|
| Male | 213 | 2024 | 360842 | 0.900 |
Why?
|
| Occupational Medicine | 3 | 2008 | 114 | 0.880 |
Why?
|
| Relative Value Scales | 4 | 2019 | 84 | 0.860 |
Why?
|
| Bupivacaine | 3 | 2023 | 412 | 0.860 |
Why?
|
| Glucocorticoids | 4 | 2023 | 2161 | 0.850 |
Why?
|
| Sinus Thrombosis, Intracranial | 2 | 2022 | 110 | 0.850 |
Why?
|
| Dimethyl Sulfoxide | 6 | 2016 | 251 | 0.840 |
Why?
|
| Coccyx | 1 | 2022 | 13 | 0.840 |
Why?
|
| Burnout, Professional | 3 | 2022 | 704 | 0.830 |
Why?
|
| Spinal Neoplasms | 8 | 2019 | 716 | 0.830 |
Why?
|
| Anesthesia, Spinal | 4 | 2020 | 280 | 0.830 |
Why?
|
| Conflict of Interest | 5 | 2024 | 554 | 0.830 |
Why?
|
| Physician's Role | 3 | 2020 | 917 | 0.830 |
Why?
|
| Sacrococcygeal Region | 1 | 2022 | 53 | 0.820 |
Why?
|
| United States Food and Drug Administration | 7 | 2020 | 1664 | 0.820 |
Why?
|
| Conscious Sedation | 4 | 2016 | 532 | 0.810 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2020 | 1809 | 0.810 |
Why?
|
| Female | 210 | 2024 | 392686 | 0.800 |
Why?
|
| Equipment and Supplies | 4 | 2013 | 273 | 0.800 |
Why?
|
| Cost-Benefit Analysis | 8 | 2020 | 5492 | 0.790 |
Why?
|
| Aneurysm, Ruptured | 8 | 2020 | 464 | 0.790 |
Why?
|
| Osteoporosis | 9 | 2023 | 1606 | 0.780 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.780 |
Why?
|
| Fees and Charges | 1 | 2022 | 192 | 0.770 |
Why?
|
| Petrosal Sinus Sampling | 7 | 2016 | 22 | 0.760 |
Why?
|
| Tomography, X-Ray Computed | 43 | 2024 | 20571 | 0.750 |
Why?
|
| Aged, 80 and over | 75 | 2024 | 58986 | 0.740 |
Why?
|
| American Medical Association | 4 | 2016 | 60 | 0.740 |
Why?
|
| Intracranial Thrombosis | 1 | 2022 | 108 | 0.740 |
Why?
|
| Cervical Vertebrae | 6 | 2021 | 980 | 0.740 |
Why?
|
| Vasospasm, Intracranial | 4 | 2021 | 215 | 0.730 |
Why?
|
| Peripheral Nerves | 1 | 2024 | 479 | 0.730 |
Why?
|
| Stents | 20 | 2022 | 3179 | 0.730 |
Why?
|
| Quality Assurance, Health Care | 10 | 2021 | 2169 | 0.710 |
Why?
|
| Placebo Effect | 2 | 2017 | 518 | 0.700 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2024 | 36429 | 0.700 |
Why?
|
| Compassionate Use Trials | 1 | 2020 | 50 | 0.690 |
Why?
|
| Research Design | 11 | 2019 | 6180 | 0.690 |
Why?
|
| Statistics as Topic | 2 | 2019 | 2358 | 0.680 |
Why?
|
| Single-Payer System | 1 | 2020 | 35 | 0.680 |
Why?
|
| Fentanyl | 3 | 2023 | 434 | 0.680 |
Why?
|
| Health Records, Personal | 1 | 2021 | 127 | 0.670 |
Why?
|
| Fellowships and Scholarships | 3 | 2024 | 1117 | 0.670 |
Why?
|
| Employee Performance Appraisal | 2 | 2016 | 86 | 0.670 |
Why?
|
| Joint Diseases | 1 | 2023 | 459 | 0.670 |
Why?
|
| Medical Informatics | 3 | 2016 | 733 | 0.660 |
Why?
|
| Central Nervous System Vascular Malformations | 5 | 2016 | 140 | 0.660 |
Why?
|
| Health Services | 2 | 2014 | 752 | 0.660 |
Why?
|
| Opiate Alkaloids | 1 | 2019 | 28 | 0.660 |
Why?
|
| Radioisotopes | 4 | 2009 | 499 | 0.650 |
Why?
|
| Middle Aged | 147 | 2024 | 220920 | 0.650 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5336 | 0.650 |
Why?
|
| Academies and Institutes | 2 | 2011 | 318 | 0.640 |
Why?
|
| Internal Fixators | 1 | 2020 | 183 | 0.640 |
Why?
|
| Tramadol | 1 | 2019 | 60 | 0.640 |
Why?
|
| Authorship | 1 | 2022 | 284 | 0.630 |
Why?
|
| Sodium Chloride | 1 | 2021 | 587 | 0.620 |
Why?
|
| Regenerative Medicine | 2 | 2019 | 306 | 0.610 |
Why?
|
| Editorial Policies | 3 | 2020 | 458 | 0.610 |
Why?
|
| Hypotension | 3 | 2015 | 879 | 0.610 |
Why?
|
| Neuralgia | 2 | 2016 | 615 | 0.600 |
Why?
|
| Fracture Fixation, Internal | 6 | 2023 | 973 | 0.600 |
Why?
|
| Neck | 4 | 2016 | 734 | 0.600 |
Why?
|
| Game Theory | 1 | 2017 | 23 | 0.600 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2020 | 1722 | 0.590 |
Why?
|
| Anesthesia, Local | 2 | 2023 | 277 | 0.590 |
Why?
|
| Review Literature as Topic | 3 | 2009 | 348 | 0.590 |
Why?
|
| Lower Extremity | 3 | 2020 | 1202 | 0.590 |
Why?
|
| Medicine | 2 | 2019 | 942 | 0.580 |
Why?
|
| Reproducibility of Results | 29 | 2021 | 20099 | 0.580 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2021 | 1033 | 0.570 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2020 | 305 | 0.570 |
Why?
|
| Physician Executives | 1 | 2018 | 134 | 0.570 |
Why?
|
| Health Insurance Portability and Accountability Act | 3 | 2014 | 105 | 0.570 |
Why?
|
| Hemostasis | 2 | 2014 | 467 | 0.570 |
Why?
|
| Professional Practice Location | 1 | 2017 | 56 | 0.560 |
Why?
|
| Nervous System Diseases | 5 | 2016 | 1667 | 0.560 |
Why?
|
| Vertebrobasilar Insufficiency | 3 | 2024 | 113 | 0.560 |
Why?
|
| Reperfusion | 10 | 2020 | 271 | 0.550 |
Why?
|
| Federal Government | 2 | 2017 | 267 | 0.550 |
Why?
|
| Legislation, Medical | 2 | 2014 | 98 | 0.550 |
Why?
|
| Mentors | 1 | 2022 | 661 | 0.550 |
Why?
|
| Carotid Arteries | 4 | 2018 | 941 | 0.550 |
Why?
|
| Placebos | 2 | 2021 | 1667 | 0.550 |
Why?
|
| Program Evaluation | 5 | 2017 | 2495 | 0.550 |
Why?
|
| Cerebral Infarction | 11 | 2020 | 983 | 0.540 |
Why?
|
| Platelet Function Tests | 2 | 2015 | 271 | 0.540 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2019 | 173 | 0.540 |
Why?
|
| Specialization | 3 | 2019 | 778 | 0.530 |
Why?
|
| Empyema, Subdural | 1 | 2016 | 12 | 0.530 |
Why?
|
| Myelography | 1 | 2016 | 72 | 0.530 |
Why?
|
| Adult | 116 | 2024 | 221203 | 0.520 |
Why?
|
| Episode of Care | 1 | 2016 | 128 | 0.520 |
Why?
|
| Webcasts as Topic | 1 | 2016 | 21 | 0.520 |
Why?
|
| Drug Prescriptions | 2 | 2017 | 1670 | 0.520 |
Why?
|
| Embolectomy | 2 | 2016 | 129 | 0.520 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2016 | 136 | 0.510 |
Why?
|
| Triamcinolone | 1 | 2015 | 68 | 0.510 |
Why?
|
| Betamethasone | 1 | 2015 | 49 | 0.510 |
Why?
|
| Ambulatory Care Facilities | 3 | 2012 | 935 | 0.510 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2014 | 121 | 0.510 |
Why?
|
| Diagnostic Techniques and Procedures | 2 | 2014 | 219 | 0.500 |
Why?
|
| Hemorrhage | 6 | 2024 | 3424 | 0.500 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2019 | 278 | 0.500 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 36 | 0.500 |
Why?
|
| History, 21st Century | 7 | 2017 | 1567 | 0.490 |
Why?
|
| Diagnostic Imaging | 8 | 2022 | 3530 | 0.490 |
Why?
|
| Infusions, Intra-Arterial | 7 | 2017 | 221 | 0.490 |
Why?
|
| Epidemics | 2 | 2018 | 512 | 0.490 |
Why?
|
| Population Surveillance | 2 | 2016 | 2598 | 0.490 |
Why?
|
| Meta-Analysis as Topic | 3 | 2009 | 1380 | 0.480 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2016 | 1432 | 0.480 |
Why?
|
| Bone Neoplasms | 7 | 2016 | 2529 | 0.480 |
Why?
|
| Serum | 1 | 2016 | 209 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.470 |
Why?
|
| Hydrocodone | 1 | 2014 | 48 | 0.470 |
Why?
|
| Catheters, Indwelling | 3 | 2016 | 426 | 0.470 |
Why?
|
| Patients' Rooms | 1 | 2014 | 62 | 0.470 |
Why?
|
| Methylprednisolone | 1 | 2016 | 385 | 0.470 |
Why?
|
| Buprenorphine | 1 | 2022 | 656 | 0.470 |
Why?
|
| Anesthesia | 2 | 2023 | 1595 | 0.460 |
Why?
|
| Intraoperative Complications | 2 | 2015 | 1166 | 0.460 |
Why?
|
| Venous Thrombosis | 3 | 2022 | 1303 | 0.460 |
Why?
|
| Education, Medical, Continuing | 5 | 2013 | 823 | 0.460 |
Why?
|
| Carotid Artery Diseases | 4 | 2014 | 877 | 0.460 |
Why?
|
| Rate Setting and Review | 1 | 2014 | 41 | 0.460 |
Why?
|
| Hospital Administration | 1 | 2017 | 353 | 0.460 |
Why?
|
| Autonomic Nerve Block | 1 | 2014 | 80 | 0.460 |
Why?
|
| Electronic Health Records | 6 | 2022 | 4811 | 0.450 |
Why?
|
| Observation | 3 | 2012 | 310 | 0.450 |
Why?
|
| Clinical Protocols | 6 | 2024 | 1440 | 0.450 |
Why?
|
| Consensus | 5 | 2018 | 3123 | 0.450 |
Why?
|
| Oxycodone | 1 | 2015 | 139 | 0.450 |
Why?
|
| Thoracic Vertebrae | 6 | 2022 | 597 | 0.440 |
Why?
|
| Governing Board | 1 | 2013 | 50 | 0.440 |
Why?
|
| Hospital Units | 1 | 2014 | 142 | 0.440 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2009 | 787 | 0.440 |
Why?
|
| Device Approval | 2 | 2012 | 163 | 0.440 |
Why?
|
| Laminectomy | 1 | 2014 | 225 | 0.440 |
Why?
|
| Politics | 2 | 2017 | 815 | 0.430 |
Why?
|
| Congresses as Topic | 1 | 2018 | 803 | 0.430 |
Why?
|
| Choice Behavior | 2 | 2016 | 824 | 0.430 |
Why?
|
| Catheterization, Peripheral | 2 | 2016 | 343 | 0.420 |
Why?
|
| Automation | 2 | 2013 | 586 | 0.420 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 1204 | 0.420 |
Why?
|
| Insurance, Health | 2 | 2017 | 2498 | 0.420 |
Why?
|
| Midazolam | 1 | 2014 | 266 | 0.420 |
Why?
|
| Workers' Compensation | 1 | 2013 | 150 | 0.420 |
Why?
|
| Spondylolisthesis | 1 | 2014 | 175 | 0.420 |
Why?
|
| Kyphosis | 2 | 2022 | 237 | 0.410 |
Why?
|
| Anesthetics, Intravenous | 2 | 2014 | 395 | 0.410 |
Why?
|
| Joint Instability | 1 | 2020 | 801 | 0.410 |
Why?
|
| Health Care Sector | 2 | 2013 | 195 | 0.410 |
Why?
|
| Neuronavigation | 1 | 2014 | 166 | 0.410 |
Why?
|
| Spinal Puncture | 1 | 2014 | 282 | 0.410 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2012 | 24 | 0.410 |
Why?
|
| Quality Improvement | 7 | 2018 | 3801 | 0.410 |
Why?
|
| Nurse Anesthetists | 1 | 2012 | 24 | 0.410 |
Why?
|
| Physician Assistants | 1 | 2015 | 191 | 0.410 |
Why?
|
| Enbucrilate | 1 | 2012 | 30 | 0.400 |
Why?
|
| Triage | 6 | 2023 | 986 | 0.400 |
Why?
|
| Head | 6 | 2024 | 924 | 0.400 |
Why?
|
| Arthrography | 1 | 2012 | 150 | 0.390 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 1234 | 0.390 |
Why?
|
| Angioplasty, Balloon | 4 | 2012 | 589 | 0.390 |
Why?
|
| Catheterization, Central Venous | 2 | 2016 | 526 | 0.390 |
Why?
|
| Nurse Practitioners | 1 | 2015 | 271 | 0.380 |
Why?
|
| Health Services Research | 1 | 2019 | 1812 | 0.380 |
Why?
|
| Databases, Factual | 14 | 2020 | 7967 | 0.380 |
Why?
|
| Inventories, Hospital | 1 | 2011 | 4 | 0.380 |
Why?
|
| Hunger | 2 | 2013 | 206 | 0.380 |
Why?
|
| Osteoarthritis | 1 | 2019 | 1063 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 3 | 2016 | 1179 | 0.380 |
Why?
|
| Basilar Artery | 5 | 2024 | 205 | 0.380 |
Why?
|
| Appetite | 1 | 2013 | 247 | 0.380 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2024 | 95 | 0.370 |
Why?
|
| Medicare Part A | 1 | 2011 | 40 | 0.370 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 90 | 0.370 |
Why?
|
| Patient-Centered Care | 2 | 2011 | 1421 | 0.370 |
Why?
|
| Radio Frequency Identification Device | 1 | 2011 | 24 | 0.370 |
Why?
|
| Vena Cava Filters | 2 | 2011 | 261 | 0.360 |
Why?
|
| Carotid Stenosis | 7 | 2022 | 860 | 0.360 |
Why?
|
| Faculty, Medical | 1 | 2019 | 1204 | 0.360 |
Why?
|
| Codes of Ethics | 1 | 2010 | 61 | 0.360 |
Why?
|
| Polyradiculopathy | 1 | 2010 | 23 | 0.360 |
Why?
|
| Neoplasm Metastasis | 4 | 2015 | 4915 | 0.360 |
Why?
|
| Thrombosis | 4 | 2021 | 2942 | 0.360 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 495 | 0.360 |
Why?
|
| Attitude of Health Personnel | 3 | 2020 | 3889 | 0.360 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 2373 | 0.350 |
Why?
|
| Deamino Arginine Vasopressin | 4 | 2016 | 87 | 0.350 |
Why?
|
| Product Labeling | 1 | 2011 | 76 | 0.350 |
Why?
|
| National Health Programs | 2 | 2011 | 440 | 0.350 |
Why?
|
| Prescriptions | 2 | 2023 | 386 | 0.350 |
Why?
|
| Health Personnel | 2 | 2023 | 3335 | 0.350 |
Why?
|
| Brain Mapping | 9 | 2013 | 6635 | 0.350 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 37 | 0.350 |
Why?
|
| Blood Vessels | 1 | 2016 | 1113 | 0.340 |
Why?
|
| Cicatrix | 1 | 2016 | 798 | 0.340 |
Why?
|
| Time Factors | 27 | 2021 | 39970 | 0.340 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1740 | 0.340 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2012 | 284 | 0.340 |
Why?
|
| Music Therapy | 1 | 2011 | 110 | 0.340 |
Why?
|
| Laser Therapy | 3 | 2014 | 1092 | 0.340 |
Why?
|
| Radiation Dosage | 6 | 2023 | 1958 | 0.330 |
Why?
|
| Biological Products | 1 | 2019 | 914 | 0.330 |
Why?
|
| Needs Assessment | 2 | 2015 | 1139 | 0.330 |
Why?
|
| Policy | 2 | 2022 | 508 | 0.330 |
Why?
|
| Acetabulum | 3 | 2015 | 542 | 0.330 |
Why?
|
| Fractures, Bone | 2 | 2013 | 2046 | 0.330 |
Why?
|
| Postoperative Complications | 13 | 2024 | 15633 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 10 | 2020 | 2791 | 0.330 |
Why?
|
| Practice Management, Medical | 3 | 2018 | 191 | 0.320 |
Why?
|
| Language | 4 | 2005 | 1540 | 0.320 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 728 | 0.320 |
Why?
|
| Disability Evaluation | 8 | 2023 | 1836 | 0.320 |
Why?
|
| Seasons | 1 | 2015 | 1520 | 0.320 |
Why?
|
| Bacterial Infections | 4 | 2021 | 1391 | 0.320 |
Why?
|
| Angioplasty | 4 | 2013 | 355 | 0.320 |
Why?
|
| Disease Management | 7 | 2019 | 2508 | 0.320 |
Why?
|
| Radiography | 13 | 2022 | 6965 | 0.310 |
Why?
|
| Environmental Medicine | 1 | 2008 | 15 | 0.310 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2012 | 857 | 0.310 |
Why?
|
| State Government | 1 | 2011 | 384 | 0.310 |
Why?
|
| Neurophysiology | 1 | 2009 | 144 | 0.310 |
Why?
|
| Aneurysm | 2 | 2010 | 337 | 0.310 |
Why?
|
| Food | 1 | 2013 | 774 | 0.300 |
Why?
|
| Orthopedic Procedures | 3 | 2014 | 1265 | 0.300 |
Why?
|
| Prevalence | 11 | 2020 | 15732 | 0.300 |
Why?
|
| Calcaneus | 1 | 2009 | 142 | 0.300 |
Why?
|
| Cerebral Cortex | 5 | 2016 | 5779 | 0.300 |
Why?
|
| Disclosure | 2 | 2013 | 748 | 0.300 |
Why?
|
| Anesthesiology | 1 | 2018 | 1120 | 0.300 |
Why?
|
| Hemoglobins | 1 | 2014 | 1526 | 0.300 |
Why?
|
| Sleep Deprivation | 2 | 2022 | 846 | 0.300 |
Why?
|
| Thiophenes | 1 | 2012 | 569 | 0.300 |
Why?
|
| Contrast Sensitivity | 4 | 2000 | 253 | 0.300 |
Why?
|
| Elastomers | 1 | 2008 | 69 | 0.290 |
Why?
|
| Angiography, Digital Subtraction | 6 | 2016 | 335 | 0.290 |
Why?
|
| Drug Utilization | 1 | 2014 | 1188 | 0.290 |
Why?
|
| Cerebral Hemorrhage | 4 | 2012 | 2656 | 0.290 |
Why?
|
| Social Responsibility | 1 | 2010 | 386 | 0.290 |
Why?
|
| Radiology Department, Hospital | 2 | 2022 | 406 | 0.290 |
Why?
|
| Prospective Studies | 38 | 2023 | 54426 | 0.290 |
Why?
|
| Data Interpretation, Statistical | 7 | 2014 | 2691 | 0.290 |
Why?
|
| Spinal Cord Injuries | 3 | 2009 | 925 | 0.290 |
Why?
|
| Diskectomy | 1 | 2009 | 209 | 0.280 |
Why?
|
| Radiation Monitoring | 3 | 2021 | 103 | 0.280 |
Why?
|
| Comprehension | 1 | 2012 | 621 | 0.280 |
Why?
|
| Suction | 2 | 2019 | 266 | 0.280 |
Why?
|
| Spinal Cord Compression | 2 | 2024 | 235 | 0.280 |
Why?
|
| Databases, Bibliographic | 3 | 2013 | 130 | 0.280 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2426 | 0.280 |
Why?
|
| Drug Approval | 1 | 2014 | 814 | 0.280 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2012 | 464 | 0.280 |
Why?
|
| Critical Illness | 1 | 2020 | 2723 | 0.280 |
Why?
|
| Palliative Care | 4 | 2010 | 3598 | 0.280 |
Why?
|
| Injections, Intra-Arterial | 5 | 2014 | 182 | 0.280 |
Why?
|
| Blood Pressure | 5 | 2015 | 8481 | 0.280 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 3461 | 0.280 |
Why?
|
| Patient Participation | 1 | 2016 | 1445 | 0.280 |
Why?
|
| Internship and Residency | 4 | 2024 | 5882 | 0.280 |
Why?
|
| Persistent Vegetative State | 2 | 2010 | 273 | 0.280 |
Why?
|
| Brain | 16 | 2022 | 27120 | 0.270 |
Why?
|
| Severity of Illness Index | 9 | 2015 | 15843 | 0.270 |
Why?
|
| Forecasting | 6 | 2024 | 2928 | 0.270 |
Why?
|
| Optical Illusions | 2 | 1997 | 40 | 0.270 |
Why?
|
| Eating | 1 | 2013 | 1539 | 0.270 |
Why?
|
| Patient Selection | 9 | 2022 | 4244 | 0.260 |
Why?
|
| Addison Disease | 1 | 2006 | 48 | 0.260 |
Why?
|
| Bone Screws | 2 | 2020 | 532 | 0.260 |
Why?
|
| Standard of Care | 4 | 2013 | 551 | 0.260 |
Why?
|
| Documentation | 3 | 2023 | 897 | 0.260 |
Why?
|
| Consciousness Disorders | 1 | 2010 | 441 | 0.260 |
Why?
|
| Decision Making | 3 | 2023 | 3929 | 0.260 |
Why?
|
| Endarterectomy, Carotid | 5 | 2022 | 555 | 0.260 |
Why?
|
| Efficiency | 2 | 2020 | 476 | 0.260 |
Why?
|
| Radiotherapy | 2 | 2009 | 1499 | 0.260 |
Why?
|
| Insurance Coverage | 2 | 2017 | 1940 | 0.250 |
Why?
|
| Specialty Boards | 3 | 2019 | 235 | 0.250 |
Why?
|
| Self Report | 1 | 2017 | 3725 | 0.250 |
Why?
|
| Catheter Ablation | 5 | 2024 | 2751 | 0.250 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 957 | 0.250 |
Why?
|
| Cohort Studies | 18 | 2023 | 41493 | 0.250 |
Why?
|
| Age Distribution | 5 | 2016 | 2880 | 0.250 |
Why?
|
| Feasibility Studies | 5 | 2024 | 5247 | 0.250 |
Why?
|
| Parkinsonian Disorders | 1 | 2008 | 284 | 0.250 |
Why?
|
| Motivation | 4 | 2016 | 2006 | 0.250 |
Why?
|
| Hemostatics | 3 | 2013 | 241 | 0.250 |
Why?
|
| Bone Density | 1 | 2018 | 3551 | 0.250 |
Why?
|
| Emergency Service, Hospital | 7 | 2024 | 7879 | 0.250 |
Why?
|
| Awareness | 2 | 2010 | 648 | 0.250 |
Why?
|
| Infection Control | 1 | 2012 | 982 | 0.240 |
Why?
|
| Punctures | 4 | 2016 | 366 | 0.240 |
Why?
|
| Multiple Myeloma | 2 | 2021 | 5146 | 0.240 |
Why?
|
| Ambulatory Care | 2 | 2016 | 2775 | 0.240 |
Why?
|
| Brain Infarction | 2 | 2020 | 290 | 0.240 |
Why?
|
| Multicenter Studies as Topic | 5 | 2016 | 1702 | 0.240 |
Why?
|
| Follow-Up Studies | 19 | 2023 | 39107 | 0.240 |
Why?
|
| Genes, Homeobox | 3 | 1999 | 285 | 0.240 |
Why?
|
| Cost Control | 3 | 2017 | 628 | 0.230 |
Why?
|
| Quality of Life | 9 | 2023 | 13367 | 0.230 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 1924 | 0.230 |
Why?
|
| Adrenocorticotropic Hormone | 4 | 2016 | 618 | 0.230 |
Why?
|
| Implantable Neurostimulators | 1 | 2024 | 75 | 0.230 |
Why?
|
| Cost of Illness | 1 | 2014 | 1936 | 0.230 |
Why?
|
| Gadolinium DTPA | 3 | 2013 | 823 | 0.220 |
Why?
|
| Somatosensory Cortex | 3 | 2008 | 512 | 0.220 |
Why?
|
| Contracts | 1 | 2023 | 60 | 0.220 |
Why?
|
| Intracranial Hemorrhages | 5 | 2019 | 822 | 0.220 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2020 | 1007 | 0.220 |
Why?
|
| Drug Industry | 1 | 2010 | 788 | 0.220 |
Why?
|
| History, 20th Century | 3 | 2017 | 2767 | 0.220 |
Why?
|
| Child Health Services | 1 | 2009 | 646 | 0.220 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2023 | 70 | 0.220 |
Why?
|
| Cross Infection | 1 | 2012 | 1422 | 0.210 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 126 | 0.210 |
Why?
|
| Delirium | 1 | 2015 | 1668 | 0.210 |
Why?
|
| Guideline Adherence | 2 | 2010 | 2220 | 0.210 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2008 | 246 | 0.210 |
Why?
|
| Arrestin | 2 | 1999 | 30 | 0.210 |
Why?
|
| Brain Diseases | 3 | 2020 | 1545 | 0.210 |
Why?
|
| Dissent and Disputes | 1 | 2024 | 146 | 0.210 |
Why?
|
| Middle Cerebral Artery | 5 | 2018 | 275 | 0.210 |
Why?
|
| Serpins | 2 | 2014 | 247 | 0.200 |
Why?
|
| Multiple Sclerosis | 7 | 2011 | 3220 | 0.200 |
Why?
|
| Touch | 2 | 2005 | 313 | 0.200 |
Why?
|
| Hemostatic Techniques | 1 | 2003 | 112 | 0.200 |
Why?
|
| Acetylglucosamine | 1 | 2003 | 189 | 0.200 |
Why?
|
| Radiation Protection | 2 | 2019 | 424 | 0.190 |
Why?
|
| Piperazines | 1 | 2012 | 2523 | 0.190 |
Why?
|
| Observer Variation | 6 | 2017 | 2606 | 0.190 |
Why?
|
| Clinical Competence | 6 | 2015 | 4793 | 0.190 |
Why?
|
| Research | 3 | 2020 | 1982 | 0.190 |
Why?
|
| Eye Proteins | 3 | 2014 | 633 | 0.190 |
Why?
|
| Nerve Growth Factors | 2 | 2014 | 564 | 0.190 |
Why?
|
| Nerve Net | 2 | 2010 | 2291 | 0.190 |
Why?
|
| Equipment Design | 3 | 2016 | 3511 | 0.180 |
Why?
|
| Industry | 2 | 2015 | 364 | 0.180 |
Why?
|
| Blindness, Cortical | 1 | 2000 | 17 | 0.180 |
Why?
|
| Trauma Centers | 2 | 2024 | 937 | 0.180 |
Why?
|
| Injections | 3 | 2023 | 831 | 0.180 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 1668 | 0.180 |
Why?
|
| Public Health | 1 | 2014 | 2669 | 0.180 |
Why?
|
| Arteriovenous Fistula | 2 | 2015 | 319 | 0.180 |
Why?
|
| Chronic Disease | 8 | 2020 | 9319 | 0.180 |
Why?
|
| Crystallography, X-Ray | 6 | 1999 | 1990 | 0.180 |
Why?
|
| Pituitary ACTH Hypersecretion | 4 | 2016 | 179 | 0.180 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1997 | 166 | 0.170 |
Why?
|
| Patient Care Team | 5 | 2019 | 2521 | 0.170 |
Why?
|
| Contrast Media | 9 | 2020 | 5311 | 0.170 |
Why?
|
| Oral Surgical Procedures, Preprosthetic | 1 | 1999 | 28 | 0.170 |
Why?
|
| Reoperation | 4 | 2018 | 4303 | 0.170 |
Why?
|
| Aspartic Acid | 3 | 2011 | 576 | 0.170 |
Why?
|
| Curettage | 1 | 2019 | 74 | 0.170 |
Why?
|
| Cataract Extraction | 3 | 2014 | 467 | 0.170 |
Why?
|
| Vision, Ocular | 2 | 2000 | 455 | 0.170 |
Why?
|
| Alcoholism | 4 | 1999 | 1973 | 0.160 |
Why?
|
| Comorbidity | 7 | 2017 | 10508 | 0.160 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1174 | 0.160 |
Why?
|
| Dental Restoration Failure | 1 | 1999 | 155 | 0.160 |
Why?
|
| Double-Blind Method | 3 | 2023 | 12341 | 0.160 |
Why?
|
| Iodine | 2 | 2012 | 288 | 0.160 |
Why?
|
| Umbilical Cord | 1 | 2020 | 177 | 0.160 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 164 | 0.160 |
Why?
|
| Device Removal | 1 | 2023 | 630 | 0.160 |
Why?
|
| Medullary Sponge Kidney | 1 | 2018 | 2 | 0.160 |
Why?
|
| After-Hours Care | 1 | 2019 | 102 | 0.150 |
Why?
|
| Cartilage | 1 | 2022 | 806 | 0.150 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 231 | 0.150 |
Why?
|
| Temporal Lobe | 3 | 2005 | 1695 | 0.150 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2020 | 263 | 0.150 |
Why?
|
| Pattern Recognition, Visual | 2 | 2010 | 823 | 0.150 |
Why?
|
| Maxillary Sinus | 1 | 1999 | 180 | 0.150 |
Why?
|
| Flank Pain | 1 | 2018 | 43 | 0.150 |
Why?
|
| False Positive Reactions | 1 | 2020 | 957 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2021 | 248 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2014 | 361 | 0.150 |
Why?
|
| Flicker Fusion | 1 | 1997 | 14 | 0.150 |
Why?
|
| Heroin | 1 | 2018 | 119 | 0.150 |
Why?
|
| Income | 3 | 2016 | 1877 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 256 | 0.150 |
Why?
|
| Osteolysis | 1 | 2019 | 275 | 0.150 |
Why?
|
| Workflow | 2 | 2020 | 851 | 0.140 |
Why?
|
| Alanine | 1 | 2020 | 609 | 0.140 |
Why?
|
| Blood Platelets | 2 | 2020 | 2479 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 173 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 3 | 2017 | 1792 | 0.140 |
Why?
|
| Referral and Consultation | 4 | 2019 | 3600 | 0.140 |
Why?
|
| Computers, Handheld | 2 | 2016 | 210 | 0.140 |
Why?
|
| Cognition | 3 | 2016 | 6992 | 0.140 |
Why?
|
| Verbal Behavior | 2 | 2010 | 335 | 0.140 |
Why?
|
| Inpatients | 3 | 2019 | 2548 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2020 | 262 | 0.140 |
Why?
|
| Syndrome | 3 | 2020 | 3267 | 0.140 |
Why?
|
| Chest Pain | 1 | 2023 | 1091 | 0.130 |
Why?
|
| Writing | 2 | 2015 | 199 | 0.130 |
Why?
|
| Lumbosacral Plexus | 1 | 2016 | 51 | 0.130 |
Why?
|
| Cataract | 2 | 2014 | 832 | 0.130 |
Why?
|
| Warfarin | 1 | 2005 | 1483 | 0.130 |
Why?
|
| Sensitivity and Specificity | 14 | 2014 | 14666 | 0.130 |
Why?
|
| Telemedicine | 3 | 2021 | 3052 | 0.130 |
Why?
|
| Cerebral Arteries | 1 | 2018 | 490 | 0.130 |
Why?
|
| Sample Size | 1 | 2019 | 841 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 513 | 0.130 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 495 | 0.130 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
| Models, Economic | 2 | 2019 | 716 | 0.130 |
Why?
|
| Fees, Medical | 1 | 2016 | 111 | 0.130 |
Why?
|
| Preoperative Care | 3 | 2000 | 2242 | 0.130 |
Why?
|
| Administrative Personnel | 1 | 2017 | 184 | 0.130 |
Why?
|
| Pilot Projects | 5 | 2021 | 8633 | 0.130 |
Why?
|
| China | 2 | 2020 | 2374 | 0.130 |
Why?
|
| Hemangioma | 1 | 2020 | 727 | 0.130 |
Why?
|
| Analgesia | 1 | 2020 | 461 | 0.120 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 846 | 0.120 |
Why?
|
| Leadership | 2 | 2018 | 1385 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2023 | 1189 | 0.120 |
Why?
|
| Compensation and Redress | 1 | 2015 | 66 | 0.120 |
Why?
|
| Risk | 4 | 2016 | 9610 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2016 | 2979 | 0.120 |
Why?
|
| Universities | 1 | 2020 | 993 | 0.120 |
Why?
|
| Risk Factors | 16 | 2022 | 74213 | 0.120 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1999 | 117 | 0.120 |
Why?
|
| Genes, Insect | 1 | 1995 | 264 | 0.120 |
Why?
|
| Workload | 2 | 2018 | 844 | 0.120 |
Why?
|
| Fasting | 2 | 2013 | 1603 | 0.120 |
Why?
|
| Cost Savings | 2 | 2019 | 913 | 0.120 |
Why?
|
| Nociceptors | 1 | 1998 | 461 | 0.120 |
Why?
|
| Patient Transfer | 2 | 2021 | 794 | 0.120 |
Why?
|
| Chordoma | 1 | 2018 | 347 | 0.120 |
Why?
|
| Anesthesia, Caudal | 1 | 2014 | 33 | 0.120 |
Why?
|
| Bone Transplantation | 1 | 1999 | 929 | 0.120 |
Why?
|
| Publishing | 2 | 2020 | 833 | 0.120 |
Why?
|
| Young Adult | 18 | 2020 | 59255 | 0.120 |
Why?
|
| Viral Vaccines | 1 | 2020 | 596 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 644 | 0.120 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 973 | 0.120 |
Why?
|
| Constriction, Pathologic | 2 | 2023 | 1096 | 0.120 |
Why?
|
| Combined Modality Therapy | 7 | 2021 | 8528 | 0.120 |
Why?
|
| Nursing Care | 1 | 2015 | 65 | 0.120 |
Why?
|
| Adipose Tissue | 6 | 1997 | 3312 | 0.120 |
Why?
|
| DNA | 3 | 1997 | 7213 | 0.120 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2012 | 138 | 0.120 |
Why?
|
| Refusal to Participate | 1 | 2014 | 31 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 6 | 2017 | 2727 | 0.110 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 236 | 0.110 |
Why?
|
| Silo Filler's Disease | 1 | 1993 | 1 | 0.110 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 300 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2016 | 350 | 0.110 |
Why?
|
| Alcohol Drinking | 2 | 1997 | 4028 | 0.110 |
Why?
|
| Inflation, Economic | 1 | 2014 | 30 | 0.110 |
Why?
|
| Musculoskeletal Diseases | 1 | 2020 | 598 | 0.110 |
Why?
|
| Injections, Intravenous | 3 | 2012 | 1379 | 0.110 |
Why?
|
| Gross Domestic Product | 1 | 2014 | 78 | 0.110 |
Why?
|
| Management Audit | 1 | 2013 | 23 | 0.110 |
Why?
|
| Telephone | 1 | 2017 | 627 | 0.110 |
Why?
|
| Kidney Calculi | 1 | 2018 | 463 | 0.110 |
Why?
|
| Anti-Anxiety Agents | 1 | 2016 | 397 | 0.110 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 1258 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2019 | 947 | 0.110 |
Why?
|
| Length of Stay | 2 | 2017 | 6426 | 0.110 |
Why?
|
| Ethanol | 2 | 2018 | 1324 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2021 | 1223 | 0.110 |
Why?
|
| Drug and Narcotic Control | 1 | 2014 | 144 | 0.110 |
Why?
|
| Perfusion Imaging | 1 | 2014 | 196 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 1069 | 0.110 |
Why?
|
| Efficiency, Organizational | 3 | 2017 | 695 | 0.110 |
Why?
|
| Vaccination | 2 | 2023 | 3384 | 0.110 |
Why?
|
| Intermittent Claudication | 1 | 2015 | 304 | 0.110 |
Why?
|
| Government Agencies | 1 | 2013 | 160 | 0.100 |
Why?
|
| Acute Disease | 7 | 2019 | 7237 | 0.100 |
Why?
|
| Operating Rooms | 1 | 2019 | 789 | 0.100 |
Why?
|
| Neurosciences | 1 | 2017 | 367 | 0.100 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 6312 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2016 | 7054 | 0.100 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2014 | 195 | 0.100 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2013 | 88 | 0.100 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 7827 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 420 | 0.100 |
Why?
|
| Cushing Syndrome | 2 | 2011 | 241 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2016 | 485 | 0.100 |
Why?
|
| Meningeal Arteries | 2 | 2024 | 68 | 0.100 |
Why?
|
| Algorithms | 4 | 2019 | 14032 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 847 | 0.100 |
Why?
|
| Dietary Fats | 4 | 1997 | 1995 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 1999 | 1420 | 0.100 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 2759 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 2693 | 0.100 |
Why?
|
| Cesarean Section | 2 | 2000 | 1398 | 0.100 |
Why?
|
| Hospitals | 3 | 2021 | 3882 | 0.100 |
Why?
|
| Visual Perception | 3 | 2000 | 1389 | 0.100 |
Why?
|
| Clot Retraction | 1 | 2011 | 13 | 0.100 |
Why?
|
| Attention | 2 | 2005 | 2396 | 0.100 |
Why?
|
| Prostheses and Implants | 3 | 2024 | 1271 | 0.100 |
Why?
|
| Probability | 1 | 2017 | 2477 | 0.100 |
Why?
|
| Arm | 1 | 2015 | 589 | 0.100 |
Why?
|
| Visual Cortex | 2 | 2000 | 1108 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2014 | 412 | 0.100 |
Why?
|
| Perioperative Period | 1 | 2013 | 250 | 0.100 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 534 | 0.090 |
Why?
|
| Animals | 28 | 2016 | 168467 | 0.090 |
Why?
|
| Europe | 1 | 2018 | 3422 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2021 | 23996 | 0.090 |
Why?
|
| Dental Implants | 1 | 1999 | 795 | 0.090 |
Why?
|
| Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
| Pain Clinics | 1 | 2011 | 50 | 0.090 |
Why?
|
| Cues | 2 | 2013 | 875 | 0.090 |
Why?
|
| Taxes | 1 | 2013 | 221 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 187 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2000 | 1231 | 0.090 |
Why?
|
| Postural Balance | 1 | 2015 | 622 | 0.090 |
Why?
|
| Vertebral Artery Dissection | 1 | 2011 | 51 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2297 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 668 | 0.090 |
Why?
|
| Malpractice | 1 | 2015 | 556 | 0.090 |
Why?
|
| Physical Stimulation | 2 | 2005 | 517 | 0.090 |
Why?
|
| Prostatic Hyperplasia | 1 | 2014 | 521 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2017 | 3429 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2013 | 292 | 0.090 |
Why?
|
| Drosophila Proteins | 2 | 1999 | 1699 | 0.090 |
Why?
|
| Motor Activity | 1 | 2000 | 2715 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 1999 | 2416 | 0.090 |
Why?
|
| Reaction Time | 2 | 2016 | 2089 | 0.090 |
Why?
|
| International Educational Exchange | 1 | 2010 | 49 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 251 | 0.090 |
Why?
|
| Health Care Rationing | 1 | 2013 | 437 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2011 | 3769 | 0.090 |
Why?
|
| Needles | 1 | 2013 | 451 | 0.090 |
Why?
|
| Nurse Administrators | 1 | 2010 | 45 | 0.090 |
Why?
|
| Automobiles | 1 | 2010 | 111 | 0.090 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 15266 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1132 | 0.090 |
Why?
|
| Adolescent | 24 | 2019 | 88324 | 0.090 |
Why?
|
| Fatty Acids | 3 | 1997 | 1808 | 0.090 |
Why?
|
| Philosophy | 1 | 2010 | 68 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1989 | 393 | 0.080 |
Why?
|
| Organizational Innovation | 1 | 2013 | 537 | 0.080 |
Why?
|
| Outpatients | 2 | 2020 | 1597 | 0.080 |
Why?
|
| Echo-Planar Imaging | 3 | 1999 | 663 | 0.080 |
Why?
|
| Prognosis | 8 | 2017 | 29629 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 4016 | 0.080 |
Why?
|
| Models, Organizational | 1 | 2013 | 546 | 0.080 |
Why?
|
| Radio Waves | 1 | 2011 | 251 | 0.080 |
Why?
|
| Logistic Models | 5 | 2019 | 13255 | 0.080 |
Why?
|
| Ischemia | 1 | 2018 | 1883 | 0.080 |
Why?
|
| Venous Insufficiency | 1 | 2010 | 108 | 0.080 |
Why?
|
| Reward | 2 | 2013 | 971 | 0.080 |
Why?
|
| Lenses, Intraocular | 1 | 1991 | 139 | 0.080 |
Why?
|
| Brain Stem | 2 | 2014 | 858 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6484 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2016 | 2115 | 0.080 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2012 | 200 | 0.080 |
Why?
|
| Food Preferences | 2 | 2012 | 398 | 0.080 |
Why?
|
| Quadriplegia | 1 | 2010 | 226 | 0.080 |
Why?
|
| Neural Inhibition | 2 | 2008 | 590 | 0.080 |
Why?
|
| Nurse's Role | 1 | 2010 | 188 | 0.080 |
Why?
|
| Nicardipine | 1 | 2008 | 60 | 0.080 |
Why?
|
| Glasgow Coma Scale | 1 | 2010 | 580 | 0.080 |
Why?
|
| Hospitals, General | 1 | 2013 | 798 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 1991 | 389 | 0.080 |
Why?
|
| Airway Obstruction | 1 | 1993 | 661 | 0.080 |
Why?
|
| Pain, Intractable | 1 | 2009 | 132 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2014 | 2281 | 0.080 |
Why?
|
| Artifacts | 2 | 2014 | 1911 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 2220 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2018 | 1286 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1265 | 0.080 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2011 | 537 | 0.080 |
Why?
|
| Catheters | 1 | 2011 | 427 | 0.080 |
Why?
|
| Photic Stimulation | 2 | 2013 | 1987 | 0.080 |
Why?
|
| Data Collection | 2 | 2019 | 3322 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 1273 | 0.070 |
Why?
|
| Drug Labeling | 1 | 2010 | 248 | 0.070 |
Why?
|
| Mandibular Fractures | 1 | 2008 | 76 | 0.070 |
Why?
|
| Population Groups | 1 | 2009 | 208 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 1923 | 0.070 |
Why?
|
| Neoplasms | 3 | 2023 | 22173 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4319 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3060 | 0.070 |
Why?
|
| Time | 1 | 2009 | 546 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21017 | 0.070 |
Why?
|
| Protein Conformation | 4 | 1999 | 3968 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 307 | 0.070 |
Why?
|
| Leg | 1 | 2012 | 1088 | 0.070 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 1505 | 0.070 |
Why?
|
| Alberta | 2 | 2020 | 68 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2014 | 2919 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 633 | 0.070 |
Why?
|
| Carotid Artery, Internal | 3 | 2018 | 445 | 0.070 |
Why?
|
| Arthroplasty | 1 | 2009 | 313 | 0.070 |
Why?
|
| Image Enhancement | 2 | 2013 | 2885 | 0.070 |
Why?
|
| Chymopapain | 1 | 2006 | 4 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2007 | 97 | 0.070 |
Why?
|
| Movement | 3 | 2008 | 1479 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 1995 | 1712 | 0.070 |
Why?
|
| Functional Laterality | 3 | 2010 | 2257 | 0.070 |
Why?
|
| Patient Discharge | 3 | 2014 | 3443 | 0.070 |
Why?
|
| Informed Consent | 2 | 2023 | 1008 | 0.070 |
Why?
|
| Platinum | 1 | 2007 | 220 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 9031 | 0.070 |
Why?
|
| Nuclear Medicine | 1 | 2009 | 237 | 0.070 |
Why?
|
| Mortality | 1 | 2017 | 2901 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 1624 | 0.070 |
Why?
|
| Students, Medical | 1 | 2019 | 1936 | 0.070 |
Why?
|
| Creatine | 2 | 2007 | 427 | 0.070 |
Why?
|
| Radiometry | 2 | 2009 | 813 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 2319 | 0.060 |
Why?
|
| Tinnitus | 1 | 2008 | 196 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2012 | 1235 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2009 | 446 | 0.060 |
Why?
|
| Utilization Review | 1 | 2007 | 382 | 0.060 |
Why?
|
| Encephalomalacia | 1 | 2005 | 18 | 0.060 |
Why?
|
| Child | 13 | 2023 | 80156 | 0.060 |
Why?
|
| Safety Management | 1 | 2011 | 760 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2016 | 9002 | 0.060 |
Why?
|
| Reference Values | 3 | 2021 | 4920 | 0.060 |
Why?
|
| Base Composition | 2 | 1995 | 290 | 0.060 |
Why?
|
| Patients | 2 | 2024 | 907 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12059 | 0.060 |
Why?
|
| Time and Motion Studies | 2 | 2015 | 143 | 0.060 |
Why?
|
| Cytokines | 1 | 2020 | 7396 | 0.060 |
Why?
|
| Craniocerebral Trauma | 2 | 2010 | 490 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2013 | 2116 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2013 | 1324 | 0.060 |
Why?
|
| Italy | 2 | 2020 | 842 | 0.060 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2004 | 54 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 1995 | 1654 | 0.060 |
Why?
|
| Pressure | 1 | 2008 | 1154 | 0.060 |
Why?
|
| Tibia | 1 | 2010 | 1070 | 0.060 |
Why?
|
| Organizational Case Studies | 2 | 2017 | 301 | 0.060 |
Why?
|
| Cardiology | 1 | 2015 | 1656 | 0.060 |
Why?
|
| Suburban Population | 1 | 2023 | 53 | 0.060 |
Why?
|
| Movement Disorders | 1 | 2008 | 459 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 2 | 1999 | 882 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 876 | 0.060 |
Why?
|
| Hydroxyapatites | 1 | 2023 | 73 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2644 | 0.060 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2007 | 258 | 0.060 |
Why?
|
| Prenatal Diagnosis | 5 | 1989 | 1265 | 0.060 |
Why?
|
| Surgical Equipment | 1 | 2003 | 57 | 0.050 |
Why?
|
| Carcinoma | 1 | 2015 | 2330 | 0.050 |
Why?
|
| Motor Neurons | 2 | 2007 | 870 | 0.050 |
Why?
|
| Gastric Bypass | 1 | 2012 | 818 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 3627 | 0.050 |
Why?
|
| Cystic Fibrosis | 2 | 1992 | 1285 | 0.050 |
Why?
|
| Methylmethacrylate | 1 | 2003 | 39 | 0.050 |
Why?
|
| Fixation, Ocular | 1 | 2005 | 242 | 0.050 |
Why?
|
| Age Factors | 9 | 2012 | 18398 | 0.050 |
Why?
|
| Sensory Thresholds | 2 | 1997 | 377 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 382 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2008 | 751 | 0.050 |
Why?
|
| Hand | 3 | 2008 | 903 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2023 | 223 | 0.050 |
Why?
|
| Adenoma | 1 | 2013 | 2160 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 2898 | 0.050 |
Why?
|
| Negotiating | 1 | 2024 | 150 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 2895 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 1995 | 3847 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 1989 | 1866 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1999 | 13446 | 0.050 |
Why?
|
| Infusions, Intravenous | 3 | 2012 | 2218 | 0.050 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 12975 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 1213 | 0.050 |
Why?
|
| Dioxanes | 1 | 2021 | 36 | 0.050 |
Why?
|
| Occupational Health | 1 | 2008 | 806 | 0.050 |
Why?
|
| Equipment Safety | 1 | 2022 | 249 | 0.050 |
Why?
|
| Boston | 2 | 2017 | 9326 | 0.050 |
Why?
|
| Headache | 2 | 2024 | 1256 | 0.050 |
Why?
|
| Air | 1 | 2021 | 187 | 0.050 |
Why?
|
| Disease Progression | 4 | 2017 | 13510 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 1999 | 17635 | 0.050 |
Why?
|
| Energy Metabolism | 3 | 1989 | 2882 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 916 | 0.050 |
Why?
|
| Massachusetts | 4 | 2018 | 8830 | 0.050 |
Why?
|
| Auditory Cortex | 1 | 2005 | 363 | 0.050 |
Why?
|
| Interferometry | 2 | 1991 | 100 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3744 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2009 | 1661 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2011 | 1813 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 1371 | 0.040 |
Why?
|
| Registries | 3 | 2017 | 8224 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 2000 | 126 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2005 | 1235 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2013 | 4446 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 5440 | 0.040 |
Why?
|
| Circle of Willis | 2 | 2015 | 78 | 0.040 |
Why?
|
| Lung | 3 | 1999 | 10002 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 795 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2011 | 9646 | 0.040 |
Why?
|
| Abdomen | 2 | 2014 | 1128 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 26127 | 0.040 |
Why?
|
| Optic Chiasm | 1 | 2000 | 91 | 0.040 |
Why?
|
| Program Development | 2 | 2017 | 1297 | 0.040 |
Why?
|
| Drosophila | 2 | 1999 | 1495 | 0.040 |
Why?
|
| Amnesia, Transient Global | 1 | 1999 | 20 | 0.040 |
Why?
|
| Life Tables | 1 | 1999 | 364 | 0.040 |
Why?
|
| Heart Rate | 1 | 2011 | 4195 | 0.040 |
Why?
|
| Motor Cortex | 1 | 2007 | 1007 | 0.040 |
Why?
|
| Medical Errors | 2 | 2022 | 1263 | 0.040 |
Why?
|
| Ultrasonography | 6 | 2001 | 5972 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2011 | 3359 | 0.040 |
Why?
|
| Respiratory Mechanics | 2 | 1994 | 699 | 0.040 |
Why?
|
| Obesity | 5 | 1989 | 12947 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 1222 | 0.040 |
Why?
|
| Jaw, Edentulous | 1 | 1999 | 99 | 0.040 |
Why?
|
| Dominance, Cerebral | 1 | 2000 | 623 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5305 | 0.040 |
Why?
|
| Models, Molecular | 3 | 1999 | 5439 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2016 | 1428 | 0.040 |
Why?
|
| Thermosensing | 1 | 1998 | 55 | 0.040 |
Why?
|
| Angiography | 2 | 2014 | 1595 | 0.040 |
Why?
|
| Static Electricity | 1 | 1999 | 261 | 0.040 |
Why?
|
| Research Report | 2 | 2012 | 367 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 7407 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 6534 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 181 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2005 | 807 | 0.040 |
Why?
|
| Arteries | 1 | 2003 | 1123 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1999 | 373 | 0.040 |
Why?
|
| Osseointegration | 1 | 1999 | 274 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 1999 | 510 | 0.040 |
Why?
|
| Nystagmus, Physiologic | 1 | 1997 | 29 | 0.040 |
Why?
|
| Abdominal Muscles | 3 | 1994 | 169 | 0.040 |
Why?
|
| Accreditation | 2 | 2012 | 473 | 0.040 |
Why?
|
| Gallium | 1 | 1997 | 28 | 0.040 |
Why?
|
| Supratentorial Neoplasms | 1 | 1999 | 159 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 9610 | 0.040 |
Why?
|
| Gels | 1 | 2018 | 420 | 0.040 |
Why?
|
| Linoleic Acids | 1 | 1997 | 39 | 0.040 |
Why?
|
| Veterans | 1 | 2011 | 2649 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 891 | 0.040 |
Why?
|
| Hypertension | 1 | 1997 | 8540 | 0.040 |
Why?
|
| Osteogenesis, Distraction | 1 | 2019 | 227 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2000 | 1736 | 0.040 |
Why?
|
| Dementia | 1 | 2011 | 2689 | 0.040 |
Why?
|
| Private Practice | 1 | 2018 | 153 | 0.040 |
Why?
|
| Parietal Lobe | 2 | 2000 | 852 | 0.030 |
Why?
|
| Causality | 2 | 2014 | 1242 | 0.030 |
Why?
|
| Oleic Acid | 1 | 1997 | 92 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2567 | 0.030 |
Why?
|
| Models, Animal | 1 | 2003 | 2112 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5369 | 0.030 |
Why?
|
| Group Practice | 1 | 2018 | 151 | 0.030 |
Why?
|
| Glucose | 1 | 1989 | 4346 | 0.030 |
Why?
|
| Sumatriptan | 1 | 1997 | 66 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2022 | 816 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 37 | 0.030 |
Why?
|
| Receptors, Adrenergic | 2 | 1987 | 155 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 237 | 0.030 |
Why?
|
| Perfusion | 1 | 2021 | 1373 | 0.030 |
Why?
|
| Anxiety | 2 | 2011 | 4573 | 0.030 |
Why?
|
| Renal Artery | 1 | 1998 | 351 | 0.030 |
Why?
|
| Psychophysics | 1 | 1997 | 292 | 0.030 |
Why?
|
| Mucus | 2 | 1975 | 341 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 1999 | 390 | 0.030 |
Why?
|
| Light | 3 | 1991 | 1353 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 1469 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2000 | 389 | 0.030 |
Why?
|
| Linoleic Acid | 1 | 1997 | 158 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 2000 | 342 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1997 | 151 | 0.030 |
Why?
|
| Transcription Factors | 1 | 1995 | 12129 | 0.030 |
Why?
|
| Stress, Psychological | 2 | 2011 | 4481 | 0.030 |
Why?
|
| Inositol | 1 | 1996 | 215 | 0.030 |
Why?
|
| Recurrence | 4 | 2015 | 8466 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1995 | 145 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 1997 | 902 | 0.030 |
Why?
|
| Anterior Cerebral Artery | 1 | 2015 | 50 | 0.030 |
Why?
|
| Dental Implantation, Endosseous | 1 | 1999 | 531 | 0.030 |
Why?
|
| Reflex, Stretch | 1 | 1995 | 23 | 0.030 |
Why?
|
| Tetrazoles | 1 | 2021 | 909 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2014 | 1496 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 281 | 0.030 |
Why?
|
| Masseter Muscle | 1 | 1995 | 38 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 1996 | 204 | 0.030 |
Why?
|
| Australia | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Benchmarking | 1 | 2021 | 1045 | 0.030 |
Why?
|
| Fatigue | 1 | 2022 | 1552 | 0.030 |
Why?
|
| Depression | 3 | 2014 | 8124 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1998 | 785 | 0.030 |
Why?
|
| Trachea | 3 | 1975 | 1089 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2850 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2748 | 0.030 |
Why?
|
| Foot | 1 | 1998 | 575 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 2016 | 332 | 0.030 |
Why?
|
| Anesthesia, Intravenous | 1 | 1975 | 129 | 0.030 |
Why?
|
| Choline | 1 | 1996 | 515 | 0.030 |
Why?
|
| Solvents | 1 | 1995 | 295 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 365 | 0.030 |
Why?
|
| Sex Factors | 3 | 1997 | 10553 | 0.030 |
Why?
|
| Infant | 6 | 2014 | 36192 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 240 | 0.030 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.030 |
Why?
|
| Base Sequence | 2 | 1995 | 12441 | 0.030 |
Why?
|
| Survival Rate | 1 | 2008 | 12725 | 0.030 |
Why?
|
| Liability, Legal | 1 | 2015 | 210 | 0.030 |
Why?
|
| Systole | 1 | 1996 | 936 | 0.030 |
Why?
|
| Crisis Intervention | 1 | 1995 | 109 | 0.030 |
Why?
|
| Crystallization | 1 | 1995 | 534 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 2000 | 942 | 0.030 |
Why?
|
| Diastole | 1 | 1996 | 782 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2014 | 193 | 0.030 |
Why?
|
| Cesium Isotopes | 1 | 1973 | 2 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2018 | 697 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2014 | 3980 | 0.030 |
Why?
|
| Pregnancy | 9 | 2012 | 29876 | 0.030 |
Why?
|
| Urologic Neoplasms | 1 | 1997 | 314 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 3849 | 0.030 |
Why?
|
| Proprioception | 1 | 1994 | 133 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2122 | 0.030 |
Why?
|
| Propofol | 1 | 1999 | 603 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 783 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1997 | 1791 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2013 | 168 | 0.030 |
Why?
|
| Anthropometry | 1 | 1997 | 1349 | 0.030 |
Why?
|
| Catheterization | 1 | 1998 | 1428 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1998 | 952 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 1693 | 0.030 |
Why?
|
| Thalamus | 1 | 1999 | 1047 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 683 | 0.030 |
Why?
|
| Germany | 1 | 2014 | 875 | 0.030 |
Why?
|
| Fluorouracil | 1 | 1997 | 1642 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1998 | 1440 | 0.020 |
Why?
|
| Fetal Diseases | 2 | 1988 | 913 | 0.020 |
Why?
|
| Bronchiectasis | 1 | 1993 | 139 | 0.020 |
Why?
|
| Fetus | 3 | 1988 | 1863 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15501 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 4160 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18253 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14607 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2014 | 383 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2021 | 1978 | 0.020 |
Why?
|
| Biopsy | 1 | 2023 | 6766 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1995 | 1880 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11122 | 0.020 |
Why?
|
| Film Dosimetry | 1 | 2011 | 29 | 0.020 |
Why?
|
| School Health Services | 1 | 1995 | 384 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13642 | 0.020 |
Why?
|
| Iopamidol | 1 | 2011 | 186 | 0.020 |
Why?
|
| Motion | 1 | 2014 | 779 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 951 | 0.020 |
Why?
|
| Visual Acuity | 2 | 1991 | 2672 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Abnormalities, Multiple | 3 | 1987 | 1423 | 0.020 |
Why?
|
| Creatinine | 1 | 1996 | 1899 | 0.020 |
Why?
|
| Arvicolinae | 1 | 2010 | 21 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 793 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1996 | 909 | 0.020 |
Why?
|
| Schools, Nursing | 1 | 2010 | 4 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2639 | 0.020 |
Why?
|
| Societies, Nursing | 1 | 2010 | 22 | 0.020 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2011 | 63 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2010 | 64 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 1990 | 92 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 981 | 0.020 |
Why?
|
| Binding Sites | 2 | 1997 | 6056 | 0.020 |
Why?
|
| Gene Conversion | 1 | 1990 | 67 | 0.020 |
Why?
|
| Point Mutation | 1 | 1995 | 1595 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1997 | 783 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 1990 | 111 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 162 | 0.020 |
Why?
|
| Braces | 1 | 2011 | 138 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 2011 | 123 | 0.020 |
Why?
|
| Rehabilitation Centers | 1 | 2011 | 246 | 0.020 |
Why?
|
| Pregnancy, Prolonged | 1 | 1989 | 9 | 0.020 |
Why?
|
| Research Personnel | 1 | 2015 | 588 | 0.020 |
Why?
|
| Physician Self-Referral | 1 | 2009 | 18 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2911 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1648 | 0.020 |
Why?
|
| Fetal Monitoring | 1 | 1989 | 69 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 396 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2012 | 590 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 4948 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1699 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2875 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2010 | 325 | 0.020 |
Why?
|
| Credentialing | 1 | 2009 | 116 | 0.020 |
Why?
|
| Random Allocation | 2 | 2008 | 2395 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 2915 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1990 | 439 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2021 | 3028 | 0.020 |
Why?
|
| Skin | 1 | 2023 | 4484 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1973 | 1972 | 0.020 |
Why?
|
| Information Management | 1 | 2009 | 100 | 0.020 |
Why?
|
| Retina | 1 | 2000 | 2659 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 931 | 0.020 |
Why?
|
| Amino Acids | 1 | 1995 | 1718 | 0.020 |
Why?
|
| Dental Arch | 1 | 2008 | 43 | 0.020 |
Why?
|
| Tooth Injuries | 1 | 2008 | 18 | 0.020 |
Why?
|
| Hospices | 1 | 2011 | 245 | 0.020 |
Why?
|
| Spina Bifida Occulta | 1 | 1988 | 31 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 1989 | 141 | 0.020 |
Why?
|
| Body Water | 1 | 1989 | 340 | 0.020 |
Why?
|
| Radiography, Panoramic | 1 | 2008 | 118 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2014 | 10448 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2011 | 635 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1893 | 0.020 |
Why?
|
| Respiration | 1 | 2014 | 1657 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 1993 | 684 | 0.020 |
Why?
|
| Government Programs | 1 | 2010 | 279 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1989 | 436 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 1989 | 375 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2016 | 1819 | 0.020 |
Why?
|
| Mandibular Condyle | 1 | 2008 | 115 | 0.020 |
Why?
|
| Neural Tube Defects | 2 | 1987 | 255 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3614 | 0.020 |
Why?
|
| Walking | 1 | 2015 | 1198 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2014 | 42230 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1126 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 16986 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2011 | 398 | 0.020 |
Why?
|
| Diet, Reducing | 2 | 1985 | 485 | 0.020 |
Why?
|
| American Heart Association | 1 | 2012 | 1039 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2011 | 408 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2014 | 3687 | 0.020 |
Why?
|
| Professional Competence | 1 | 2010 | 431 | 0.020 |
Why?
|
| Isometric Contraction | 2 | 1999 | 150 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 654 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4063 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3579 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2644 | 0.020 |
Why?
|
| Lipolysis | 1 | 1987 | 212 | 0.020 |
Why?
|
| Body Weight | 4 | 1996 | 4618 | 0.020 |
Why?
|
| Family Practice | 1 | 1969 | 512 | 0.020 |
Why?
|
| Skull | 2 | 1988 | 818 | 0.020 |
Why?
|
| Curriculum | 2 | 2010 | 3743 | 0.020 |
Why?
|
| Esterification | 1 | 1985 | 39 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5774 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 1358 | 0.020 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 474 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3597 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1991 | 1814 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2007 | 441 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3603 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 763 | 0.020 |
Why?
|
| Athletic Injuries | 1 | 2015 | 1216 | 0.020 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2008 | 254 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1999 | 308 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1997 | 11742 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 1141 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 2048 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 1999 | 22176 | 0.010 |
Why?
|
| Motor Skills | 1 | 2008 | 521 | 0.010 |
Why?
|
| Glycerol | 1 | 1985 | 274 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1993 | 1230 | 0.010 |
Why?
|
| Cell Division | 1 | 1972 | 4465 | 0.010 |
Why?
|
| Life Style | 1 | 1996 | 3917 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2011 | 1460 | 0.010 |
Why?
|
| Electromyography | 3 | 1995 | 1394 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2011 | 995 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1991 | 1468 | 0.010 |
Why?
|
| Brain Concussion | 1 | 2015 | 1404 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 1997 | 1703 | 0.010 |
Why?
|
| Metabolomics | 1 | 2013 | 1659 | 0.010 |
Why?
|
| Hydrocephalus | 2 | 1988 | 764 | 0.010 |
Why?
|
| Phenobarbital | 1 | 2004 | 191 | 0.010 |
Why?
|
| Suicide | 1 | 1995 | 1601 | 0.010 |
Why?
|
| Mandible | 1 | 2008 | 753 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1996 | 11461 | 0.010 |
Why?
|
| Vertebral Artery | 1 | 2004 | 185 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 1969 | 990 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10766 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2011 | 10090 | 0.010 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 556 | 0.010 |
Why?
|
| Body Height | 1 | 1989 | 1570 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11121 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5205 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1993 | 1462 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 1173 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2651 | 0.010 |
Why?
|
| Incidence | 2 | 2014 | 21355 | 0.010 |
Why?
|
| Tidal Volume | 2 | 1994 | 488 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1990 | 2547 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2024 | 0.010 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2000 | 210 | 0.010 |
Why?
|
| Electroencephalography | 3 | 2000 | 6237 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11076 | 0.010 |
Why?
|
| Seizures | 1 | 2012 | 2957 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1987 | 1336 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 1999 | 24 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2688 | 0.010 |
Why?
|
| Feedback | 2 | 1994 | 791 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1979 | 225 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2000 | 236 | 0.010 |
Why?
|
| Mice | 4 | 2014 | 81533 | 0.010 |
Why?
|
| Temperance | 1 | 1999 | 87 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1999 | 162 | 0.010 |
Why?
|
| Hospitalization | 3 | 2018 | 10721 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12794 | 0.010 |
Why?
|
| Form Perception | 1 | 2000 | 175 | 0.010 |
Why?
|
| Tympanic Membrane | 1 | 2000 | 232 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2000 | 503 | 0.010 |
Why?
|
| Exercise | 2 | 1999 | 5890 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9489 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1997 | 17 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2001 | 911 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1990 | 2244 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2000 | 463 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5293 | 0.010 |
Why?
|
| Cyclic AMP Receptor Protein | 1 | 1997 | 23 | 0.010 |
Why?
|
| Diffusion | 1 | 1999 | 814 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1979 | 350 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1990 | 4369 | 0.010 |
Why?
|
| Lipids | 2 | 1986 | 3341 | 0.010 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2007 | 1473 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 1501 | 0.010 |
Why?
|
| Psychiatry | 1 | 1969 | 1693 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2008 | 3060 | 0.010 |
Why?
|
| Fiber Optic Technology | 2 | 1975 | 290 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11530 | 0.010 |
Why?
|
| Communication | 1 | 2011 | 3873 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9280 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 1059 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1990 | 3080 | 0.010 |
Why?
|
| Reading | 1 | 2000 | 531 | 0.010 |
Why?
|
| Motion Perception | 1 | 2000 | 374 | 0.010 |
Why?
|
| Streptokinase | 1 | 1996 | 186 | 0.010 |
Why?
|
| Vinblastine | 1 | 1997 | 488 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1999 | 906 | 0.010 |
Why?
|
| Thiopental | 1 | 1975 | 55 | 0.010 |
Why?
|
| Visual Pathways | 1 | 2000 | 551 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2000 | 840 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1997 | 681 | 0.010 |
Why?
|
| Tracheitis | 1 | 1975 | 29 | 0.010 |
Why?
|
| Halothane | 1 | 1975 | 200 | 0.010 |
Why?
|
| Bronchoscopy | 3 | 1975 | 909 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 951 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1999 | 910 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1987 | 2491 | 0.010 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 1994 | 12 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 1975 | 166 | 0.010 |
Why?
|
| Homeostasis | 1 | 1985 | 3323 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2004 | 1906 | 0.010 |
Why?
|
| Chicago | 1 | 1995 | 254 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4434 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 1979 | 492 | 0.010 |
Why?
|
| Genital Diseases, Female | 1 | 1975 | 192 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1999 | 3076 | 0.010 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1993 | 30 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1973 | 9 | 0.010 |
Why?
|
| Sepsis | 1 | 1987 | 2585 | 0.010 |
Why?
|
| Mass Screening | 1 | 1989 | 5428 | 0.010 |
Why?
|
| Thallium | 1 | 1973 | 100 | 0.010 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1993 | 80 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3306 | 0.010 |
Why?
|
| Pleura | 1 | 1994 | 245 | 0.010 |
Why?
|
| Respiratory Function Tests | 2 | 1994 | 1682 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1999 | 6228 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1993 | 175 | 0.010 |
Why?
|
| Sheep | 1 | 1975 | 1440 | 0.010 |
Why?
|
| Oxygen | 2 | 1993 | 4227 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1992 | 70 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1993 | 210 | 0.010 |
Why?
|
| Norway | 2 | 1972 | 499 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1993 | 379 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 2 | 1972 | 321 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 1992 | 142 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1994 | 458 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 1436 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1993 | 679 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 1652 | 0.010 |
Why?
|
| Dealkylation | 1 | 1990 | 2 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1990 | 90 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1997 | 2224 | 0.010 |
Why?
|
| Methotrexate | 1 | 1997 | 1719 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1990 | 190 | 0.010 |
Why?
|
| Tomatine | 1 | 1989 | 1 | 0.010 |
Why?
|
| Memory | 1 | 2000 | 2193 | 0.010 |
Why?
|
| Phloretin | 1 | 1989 | 16 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1989 | 35 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1989 | 37 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1989 | 74 | 0.010 |
Why?
|
| Infant, Postmature | 1 | 1989 | 11 | 0.010 |
Why?
|
| Cortisone | 1 | 1990 | 87 | 0.010 |
Why?
|
| Stomach | 1 | 1994 | 696 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 1147 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1972 | 395 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 6344 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1989 | 328 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1990 | 189 | 0.010 |
Why?
|
| Tritium | 1 | 1989 | 708 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1990 | 158 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1990 | 289 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1990 | 621 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1999 | 3442 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1989 | 333 | 0.000 |
Why?
|
| Triglycerides | 2 | 1987 | 2461 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1989 | 458 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1990 | 915 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1989 | 659 | 0.000 |
Why?
|
| Heparin | 1 | 1996 | 1634 | 0.000 |
Why?
|
| Meiosis | 1 | 1990 | 328 | 0.000 |
Why?
|
| Lymphatic Diseases | 1 | 1990 | 320 | 0.000 |
Why?
|
| Repressor Proteins | 1 | 1999 | 2986 | 0.000 |
Why?
|
| Dogs | 1 | 1973 | 3839 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1989 | 490 | 0.000 |
Why?
|
| Theophylline | 1 | 1987 | 131 | 0.000 |
Why?
|
| Posture | 1 | 1992 | 957 | 0.000 |
Why?
|
| Permeability | 1 | 1989 | 723 | 0.000 |
Why?
|
| Isoproterenol | 1 | 1987 | 395 | 0.000 |
Why?
|
| Equipment Failure | 1 | 1990 | 578 | 0.000 |
Why?
|
| Clonidine | 1 | 1987 | 169 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1999 | 4217 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1990 | 799 | 0.000 |
Why?
|
| Extraembryonic Membranes | 1 | 1986 | 38 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1999 | 4937 | 0.000 |
Why?
|
| Cholesterol, VLDL | 1 | 1986 | 70 | 0.000 |
Why?
|
| Mutation | 1 | 1990 | 30054 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1990 | 1519 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2269 | 0.000 |
Why?
|
| Limb Deformities, Congenital | 1 | 1986 | 136 | 0.000 |
Why?
|
| Biological Transport | 1 | 1989 | 2091 | 0.000 |
Why?
|
| Lipoproteins, VLDL | 1 | 1986 | 201 | 0.000 |
Why?
|
| Affect | 1 | 1973 | 1486 | 0.000 |
Why?
|
| Protein Binding | 1 | 1997 | 9353 | 0.000 |
Why?
|
| Hernia, Umbilical | 1 | 1986 | 102 | 0.000 |
Why?
|
| Social Support | 1 | 1995 | 2171 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1996 | 3575 | 0.000 |
Why?
|
| Thorax | 1 | 1986 | 555 | 0.000 |
Why?
|
| Kinetics | 1 | 1989 | 6374 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1990 | 2910 | 0.000 |
Why?
|
| Face | 1 | 1987 | 1026 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1993 | 26198 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1990 | 1407 | 0.000 |
Why?
|
| Gestational Age | 1 | 1989 | 3577 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1972 | 3188 | 0.000 |
Why?
|
| Scoliosis | 1 | 1986 | 741 | 0.000 |
Why?
|
| Cholesterol, HDL | 1 | 1986 | 1814 | 0.000 |
Why?
|
| Smoking | 1 | 1996 | 9053 | 0.000 |
Why?
|
| Fatty Acids, Essential | 1 | 1959 | 97 | 0.000 |
Why?
|
| Fats | 1 | 1959 | 99 | 0.000 |
Why?
|
| Cholesterol | 1 | 1986 | 2904 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1972 | 3223 | 0.000 |
Why?
|
| Cholesterol, LDL | 1 | 1986 | 2382 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1999 | 23447 | 0.000 |
Why?
|
| Genotype | 1 | 1990 | 12990 | 0.000 |
Why?
|
| Rats | 1 | 1972 | 23741 | 0.000 |
Why?
|
| Cell Line | 1 | 1989 | 15601 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1975 | 184 | 0.000 |
Why?
|
| Pentobarbital | 1 | 1975 | 153 | 0.000 |
Why?
|
| Macrophages | 1 | 1989 | 5769 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1988 | 2947 | 0.000 |
Why?
|
| Starvation | 1 | 1973 | 142 | 0.000 |
Why?
|
| Social Work, Psychiatric | 1 | 1972 | 23 | 0.000 |
Why?
|
| Hostility | 1 | 1973 | 183 | 0.000 |
Why?
|
| Paranoid Disorders | 1 | 1972 | 61 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1975 | 659 | 0.000 |
Why?
|
| Psychophysiologic Disorders | 1 | 1973 | 221 | 0.000 |
Why?
|
| Kidney | 1 | 1986 | 7047 | 0.000 |
Why?
|
| Cilia | 1 | 1975 | 495 | 0.000 |
Why?
|
| Personality Inventory | 1 | 1973 | 1019 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1969 | 6845 | 0.000 |
Why?
|
| Aggression | 1 | 1973 | 750 | 0.000 |
Why?
|
| Self Concept | 1 | 1973 | 1045 | 0.000 |
Why?
|
| Home Care Services | 1 | 1972 | 648 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1972 | 1647 | 0.000 |
Why?
|